Coronavirus information from UCLA and UCLA Health
The CNSI will re-open on June 12 for projects with approved Research Ramp-Up Plans.


The Next Generation Incubator

Niche Biomedical aims to revolutionize medical science by using bioelectronic medicine for the treatment of diseases and injuries that are pharmaceutically incurable.

Currently, there are over 50 million people that suffer from paralysis in the US with the leading causes from stroke and spinal cord injuries. High socioeconomic burdens are not only imposed to patients suffering from paralysis but to their families as well. Niche Bio is focusing on treating these diseases and injuries through both non-invasive and invasive neuromodulation solutions to re-engage the brain-spine connection. This is achieved by leveraging Niche’s expertise in physiology, neuroengineering and neural interface, prosthetic device, microelectronics, electrode and packaging technology.

Graduated in 2018
Location: TechSpace in Westwood, CA